Knegtel; Ronald Marcellus Alphonsus
Patent Applications and Registrations
Patent applications and USPTO patent grants for Knegtel; Ronald Marcellus Alphonsus.The latest application filed is for "compounds useful as inhibitors of atr kinase".
- Knegtel; Ronald Marcellus Alphonsus - Abingdon GB
| Patent | Date |
|---|---|
| Substituted pyrazin-2-amines as inhibitors of ATR kinase Grant 10,479,784 - Charrier , et al. Nov | 2019-11-19 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20190047995 - CHARRIER; Jean-Damien ; et al. | 2019-02-14 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20180155346 - Ahmad; Nadia ; et al. | 2018-06-07 |
| Compounds useful as inhibitors of ATR kinase Grant 9,718,827 - Ahmad , et al. August 1, 2 | 2017-08-01 |
| Compounds useful as inhibitors of ATR kinase Grant 9,630,956 - Charrier , et al. April 25, 2 | 2017-04-25 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160347754 - Ahmad; Nadia ; et al. | 2016-12-01 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160311809 - Charrier; Jean-Damien ; et al. | 2016-10-27 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160271129 - Charrier; Jean-Damien ; et al. | 2016-09-22 |
| Compounds useful as inhibitors of ATR kinase Grant 9,334,244 - Charrier , et al. May 10, 2 | 2016-05-10 |
| Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors Grant 9,309,250 - Storck , et al. April 12, 2 | 2016-04-12 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160009723 - Charrier; Jean-Damien ; et al. | 2016-01-14 |
| Compounds useful as inhibitors of ATR kinase Grant 9,096,584 - Charrier , et al. August 4, 2 | 2015-08-04 |
| Compounds useful as inhibitors of ATR kinase Grant 8,969,356 - Charrier , et al. March 3, 2 | 2015-03-03 |
| Compounds useful as inhibitors of ATR kinase Grant 8,962,631 - Charrier , et al. February 24, 2 | 2015-02-24 |
| Aminopyrazines as ATR kinase inhibitors Grant 8,877,759 - Charrier , et al. November 4, 2 | 2014-11-04 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20140288347 - Charrier; Jean-Damien ; et al. | 2014-09-25 |
| Kinase Inhibitors App 20140221334 - Jimenez; Juan-Miguel ; et al. | 2014-08-07 |
| Kinase inhibitors Grant 8,741,931 - Jimenez , et al. June 3, 2 | 2014-06-03 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20140113005 - Charrier; Jean-Damien ; et al. | 2014-04-24 |
| Compounds useful as inhibitors of ATR kinase Grant 8,623,869 - Charrier , et al. January 7, 2 | 2014-01-07 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20130095193 - Charrier; Jean-Damien ; et al. | 2013-04-18 |
| Compounds useful as inhibitors of ATR kinase Grant 8,410,112 - Charrier , et al. April 2, 2 | 2013-04-02 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20130034616 - Storck; Pierre-Henri ; et al. | 2013-02-07 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120177748 - Charrier; Jean-Damien ; et al. | 2012-07-12 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120122884 - Charrier; Jean-Damien ; et al. | 2012-05-17 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120046295 - Charrier; Jean-Damien ; et al. | 2012-02-23 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120027874 - Charrier; Jean-Damien ; et al. | 2012-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 